Impact of cancer and cardiovascular disease on in-hospital outcomes of COVID-19 patients: results from the american heart association COVID-19 cardiovascular disease registry

Table 2 Predictors of in-hospital all-cause mortality in cancer patients admitted with symptomatic COVID-19

		Multivariable Analysis	p value
	OR	95% CI	p value
Age (per 10 years)	1.43	1.22 – 1.67	< 0.0001
Female Gender	0.59	0.44 – 0.79	0.001
BMI (per 10 units)	0.99	0.78 – 1.25	0.92
Black Race^a	1.15	0.80 – 1.65	0.46
Asian or Pacific Islander Race^a	1.43	0.80 – 2.53	0.22
Undetermined or Other Race^a	1.05	0.66 – 1.70	0.83
Diabetes	1.13	0.82 – 1.57	0.45
Hypertension	1.34	0.88 – 2.04	0.17
Hyperlipidemia	1.12	0.81 – 1.53	0.50
Smoking History	2.63	1.54 – 4.48	< 0.0001
CKD	0.85	0.60 – 1.20	0.35
Pulmonary Disease	1.47	1.03 – 2.09	0.033
CVD History	1.01	0.63 – 1.62	0.95
Chemotherapy or Biologic Therapy	1.72	1.05 – 2.80	0.030

BMI Body Mass Index, CVD Cardiovascular Disease, CI Confidence Interval, CKD Chronic Kidney Disease, OR Odds Ratio
^aAs compared to Caucasian white race

ISSN: 2057-3804